On October 9, the Hospital del Mar hosted the Fourth Scientific Session of the HUB Alzheimer Barcelona, dedicated to the role of artificial intelligence and data science in research on Alzheimer's disease and other neurodegenerative diseases.
This session is part of the HUB Scientific Sessions Series, a bimonthly initiative rotates among the various institutions that make up the HUB Alzheimer Barcelona. The cycle aims to strengthen connections between clinical and research teams at the different institutions, foster collaboration and synergies between projects, and showcase emerging research talent.
Agustín Conesa Celdrán, researcher at the Hospital del Mar, welcomed the attendees and moderated the different sessions, in which experts from different centers of the HUB presented innovative projects and shared the main results of their research.
The presentations covered topics such as machine learning, digital biomarkers, biomedical data analysis, neuroimaging, and predictive models, showing how these tools can contribute to deepening our understanding of Alzheimer's and other neurodegenerative diseases and open new opportunities for their diagnosis, monitoring and personalised treatment.
Six approaches to artificial intelligence applied to research and care
- Adrián Hinojosa, PhD (Ace Alzheimer Center Barcelona) presented “AI-Driven Medication Profiling in Alzheimer's Disease: Uncovering Polypharmacy and Cognitive Risk”, a project that uses artificial intelligence to analyze the drug treatments of people with Alzheimer's, identify situations of polypharmacy and study the possible cognitive risks associated with the use of certain medications.
- Keegan Reeve (Barcelonaβeta Brain Research Center) addressed, in “Digital Speech Markers in MCI”, the potential of digital speech analysis to identify cognitive changes associated with Alzheimer's and explore its usefulness as a non-invasive biomarker, complementary to other detection and monitoring tools.
- Cèlia Cruz (Hospital Clínic Barcelona) presented “Explainable ML to Classify FTD Subtypes with DTI Images”, an investigation that combines diffusion magnetic resonance imaging and explainable machine learning techniques to identify characteristic brain patterns and differentiate subtypes of frontotemporal dementia.
- Paula Villatoro González (Sant Pau Hospital) explained, in “Single-Cell Transcriptomics Reveals Cell-Type-Specific Signatures and Therapeutic Opportunities in CADASIL”, how bioinformatic analysis of transcriptomic data allows the identification of specific molecular alterations and the exploration of new therapeutic targets in CADASIL, an inherited disease of the small cerebral vessels.
- Çiğdem Aslay, PhD (Universitat Pompeu Fabra / visiting researcher at Hospital del Mar Research Institute) presented “Tau-CTFP: A Connectome-Informed Continuous-Time First-Passage Model for Forecasting the Onset of Regional Tau PET Abnormality”, a computational model that combines Tau PET imaging data and brain connectivity data to predict in which brain regions new alterations related to the tau protein might be detected during Alzheimer's progression.
- Martín González Calleja (Pasqual Maragall Foundation) presented “Virtual Assistant for Specialized Alzheimer's Support – Brief Demo”, a demonstration of SHERPA Alzheimer, a virtual assistant based on conversational artificial intelligence, currently under development, which seeks to facilitate access to reliable information, provide guidance on available resources and services, and offer support tailored to the needs of people with Alzheimer's, their families, and professionals.
The event included a discussion forum and a question and answer session, which allowed attendees to share perspectives and delve deeper into some of the topics addressed during the presentations.
The meeting concluded with closing remarks from Pablo Villoslada, head of the Neurology Service at Hospital del Mar and member of the HUB Operational Committee. Afterwards, the attendees were able to enjoy a networking lunch and a guided tour of different research laboratories of the Hospital del Mar Research Institute, located in the Parc de Recerca Biomèdica de Barcelona (PRBB).
The session was, therefore, a space for sharing knowledge, identifying potential synergies, and strengthening collaboration among the teams working to advance research into Alzheimer's and other neurodegenerative diseases.